These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 30596291)

  • 41. Delivery of platinum(IV) drug to subcutaneous tumor and lung metastasis using bradykinin-potentiating peptide-decorated chitosan nanoparticles.
    Wang X; Yang C; Zhang Y; Zhen X; Wu W; Jiang X
    Biomaterials; 2014 Aug; 35(24):6439-53. PubMed ID: 24811257
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Co-delivery of doxorubicin and interleukin-2 via chitosan based nanoparticles for enhanced antitumor efficacy.
    Wu J; Tang C; Yin C
    Acta Biomater; 2017 Jan; 47():81-90. PubMed ID: 27729232
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Development of drug-loaded chitosan-vanillin nanoparticles and its cytotoxicity against HT-29 cells.
    Li PW; Wang G; Yang ZM; Duan W; Peng Z; Kong LX; Wang QH
    Drug Deliv; 2016; 23(1):30-5. PubMed ID: 24712731
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Fabrication and biological evaluation of chitosan coated hyaluronic acid-docetaxel conjugate nanoparticles in CD44(+) cancer cells.
    Shabani Ravari N; Goodarzi N; Alvandifar F; Amini M; Souri E; Khoshayand MR; Hadavand Mirzaie Z; Atyabi F; Dinarvand R
    Daru; 2016 Jul; 24(1):21. PubMed ID: 27473554
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Transferrin functionalized chitosan-PEG nanoparticles for targeted delivery of paclitaxel to cancer cells.
    Nag M; Gajbhiye V; Kesharwani P; Jain NK
    Colloids Surf B Biointerfaces; 2016 Dec; 148():363-370. PubMed ID: 27632697
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Doxorubicin and siRNA Codelivery via Chitosan-Coated pH-Responsive Mixed Micellar Polyplexes for Enhanced Cancer Therapy in Multidrug-Resistant Tumors.
    Butt AM; Amin MC; Katas H; Abdul Murad NA; Jamal R; Kesharwani P
    Mol Pharm; 2016 Dec; 13(12):4179-4190. PubMed ID: 27934479
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Natural Polymeric Nanoparticles for Brain-Targeting: Implications on Drug and Gene Delivery.
    Elzoghby AO; Abd-Elwakil MM; Abd-Elsalam K; Elsayed MT; Hashem Y; Mohamed O
    Curr Pharm Des; 2016; 22(22):3305-23. PubMed ID: 26845323
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Verapamil delivery systems on the basis of mesoporous ZSM-5/KIT-6 and ZSM-5/SBA-15 polymer nanocomposites as a potential tool to overcome MDR in cancer cells.
    Popova M; Mihaylova R; Momekov G; Momekova D; Lazarova H; Trendafilova I; Mitova V; Koseva N; Mihályi J; Shestakova P; St Petkov P; Aleksandrov HA; Vayssilov GN; Konstantinov S; Szegedi Á
    Eur J Pharm Biopharm; 2019 Sep; 142():460-472. PubMed ID: 31336182
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Rapid and soft formulation of folate-functionalized nanoparticles for the targeted delivery of tripentone in ovarian carcinoma.
    Tomasina J; Poulain L; Abeilard E; Giffard F; Brotin E; Carduner L; Carreiras F; Gauduchon P; Rault S; Malzert-Fréon A
    Int J Pharm; 2013 Dec; 458(1):197-207. PubMed ID: 24084450
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ligand decorated chitosan as an advanced nanocarrier for targeted delivery: a critical review.
    Qindeel M; Ahmed N; Khan GM; Rehman AU
    Nanomedicine (Lond); 2019 Jun; 14(12):1623-1642. PubMed ID: 31166147
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Biodistribution and pharmacokinetics of Mad2 siRNA-loaded EGFR-targeted chitosan nanoparticles in cisplatin sensitive and resistant lung cancer models.
    Nascimento AV; Gattacceca F; Singh A; Bousbaa H; Ferreira D; Sarmento B; Amiji MM
    Nanomedicine (Lond); 2016 Apr; 11(7):767-81. PubMed ID: 26980454
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Chitosan-Based Drug Delivery Systems for Optimization of Photodynamic Therapy: a Review.
    Calixto GMF; de Annunzio SR; Victorelli FD; Frade ML; Ferreira PS; Chorilli M; Fontana CR
    AAPS PharmSciTech; 2019 Jul; 20(7):253. PubMed ID: 31309346
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Chitosan (CMD)-mediated co-delivery of SN38 and Snail-specific siRNA as a useful anticancer approach against prostate cancer.
    Afkham A; Aghebati-Maleki L; Siahmansouri H; Sadreddini S; Ahmadi M; Dolati S; Afkham NM; Akbarzadeh P; Jadidi-Niaragh F; Younesi V; Yousefi M
    Pharmacol Rep; 2018 Jun; 70(3):418-425. PubMed ID: 29626645
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Overview of the preparation of organic polymeric nanoparticles for drug delivery based on gelatine, chitosan, poly(d,l-lactide-co-glycolic acid) and polyalkylcyanoacrylate.
    Lai P; Daear W; Löbenberg R; Prenner EJ
    Colloids Surf B Biointerfaces; 2014 Jun; 118():154-63. PubMed ID: 24769392
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Oleanolic-bioenhancer coloaded chitosan modified nanocarriers attenuate breast cancer cells by multimode mechanism and preserve female fertility.
    Sharma M; Sharma S; Sharma V; Sharma K; Yadav SK; Dwivedi P; Agrawal S; Paliwal SK; Dwivedi AK; Maikhuri JP; Gupta G; Mishra PR; Rawat AKS
    Int J Biol Macromol; 2017 Nov; 104(Pt A):1345-1358. PubMed ID: 28591594
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Delivery of curcumin by a pH-responsive chitosan mesoporous silica nanoparticles for cancer treatment.
    Ahmadi Nasab N; Hassani Kumleh H; Beygzadeh M; Teimourian S; Kazemzad M
    Artif Cells Nanomed Biotechnol; 2018 Feb; 46(1):75-81. PubMed ID: 28278578
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Polymer-based nanoparticles for oral insulin delivery: Revisited approaches.
    Fonte P; Araújo F; Silva C; Pereira C; Reis S; Santos HA; Sarmento B
    Biotechnol Adv; 2015 Nov; 33(6 Pt 3):1342-54. PubMed ID: 25728065
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Chitosan mediated targeted drug delivery system: a review.
    Patel MP; Patel RR; Patel JK
    J Pharm Pharm Sci; 2010; 13(4):536-57. PubMed ID: 21486530
    [TBL] [Abstract][Full Text] [Related]  

  • 59. An ultrasound-controllable release system based on waterborne polyurethane/chitosan membrane for implantable enhanced anticancer therapy.
    Feng Z; Zheng Y; Zhao L; Zhang Z; Sun Y; Qiao K; Xie Y; Wang Y; He W
    Mater Sci Eng C Mater Biol Appl; 2019 Nov; 104():109944. PubMed ID: 31500058
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Natural Polysaccharides for siRNA Delivery: Nanocarriers Based on Chitosan, Hyaluronic Acid, and Their Derivatives.
    Serrano-Sevilla I; Artiga Á; Mitchell SG; De Matteis L; de la Fuente JM
    Molecules; 2019 Jul; 24(14):. PubMed ID: 31311176
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.